dr. christopher twelves on eribulin mesylate in combination therapies for breast cancer
Published 8 years ago • 229 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:36
dr. chris twelves compares eribulin and capecitabine
-
2:19
dr. twelves discusses eribulin for the treatment of breast cancer
-
1:58
dr. twelves on a pooled analysis of eribulin in breast cancer
-
15:50
professor christopher twelves, md: advancements in metastatic breast cancer from asco 2011
-
9:08
breast cancer diaries: (#14) starting eribulin & getting home [cycle 1, day 1]
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
9:31
case study 145 | congenital hydrocephalus secondary to aqueductal stenosis | explained by dr. grunch
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
1:39
dr. christopher twelves on the rising issue of metastatic breast cancer
-
10:34
christopher twelves, md: comparing eribulin and capecitabine
-
3:00
eribulin’s role in triple-negative breast cancer
-
1:02
dr. twelves on the value of the negative iniparib trial results
-
3:40
treatment with eribulin in metastatic breast cancer
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
1:58
dr. alvarez on updated findings with eribulin in patients with her2 breast cancer
-
6:10
prof. christopher twelves, md: research advances in metastatic breast cancer from asco 2011
-
1:41
dr. twelves describes iniparib clinical trials
-
11:28
recent data on eribulin in metastatic breast cancer patients from sabcs
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
1:06
dr. vahdat on capecitabine and eribulin in advanced breast cancer
-
5:25
eribulin in metastatic breast cancer